Xiaoguang Dou

3.4k total citations
72 papers, 638 citations indexed

About

Xiaoguang Dou is a scholar working on Epidemiology, Hepatology and Oncology. According to data from OpenAlex, Xiaoguang Dou has authored 72 papers receiving a total of 638 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Epidemiology, 48 papers in Hepatology and 6 papers in Oncology. Recurrent topics in Xiaoguang Dou's work include Hepatitis B Virus Studies (45 papers), Hepatitis C virus research (39 papers) and Liver Disease Diagnosis and Treatment (30 papers). Xiaoguang Dou is often cited by papers focused on Hepatitis B Virus Studies (45 papers), Hepatitis C virus research (39 papers) and Liver Disease Diagnosis and Treatment (30 papers). Xiaoguang Dou collaborates with scholars based in China, United States and France. Xiaoguang Dou's co-authors include Qiuju Sheng, Yang Ding, Han Bai, Li Ma, Yang Ding, Xiaokai Chen, Miao Liang, Yanwei Li, Chong Zhang and Qing Xie and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Clinical Microbiology and Journal of Hepatology.

In The Last Decade

Xiaoguang Dou

65 papers receiving 633 citations

Peers

Xiaoguang Dou

EPIDE

HEPAT

IMMUN

SURGE

Mei‐Hsuan Lee Taiwan

Zhiliang Gao China

Kai‐Henrik Peiffer Germany

Hatem Elalfy Egypt

Akinobu Takaki Japan

Hiromi Kan Japan

Carmela Cacciapuoti Italy

Themistoklis Vassiliadis Greece

Onofrio G. Manghisi Italy

Naglaa Zayed Egypt

Mei‐Hsuan Lee Taiwan

Xiaoguang Dou

556 ×1.4

EPIDE

518 ×1.4

HEPAT

99 ×0.9

40 ×0.6

IMMUN

64 ×1.0

SURGE

Citations per year, relative to Xiaoguang Dou Xiaoguang Dou (= 1×) peers Mei‐Hsuan Lee

Countries citing papers authored by Xiaoguang Dou

Since Specialization

Citations

This map shows the geographic impact of Xiaoguang Dou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoguang Dou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoguang Dou more than expected).

Fields of papers citing papers by Xiaoguang Dou

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoguang Dou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoguang Dou. The network helps show where Xiaoguang Dou may publish in the future.

Co-authorship network of co-authors of Xiaoguang Dou

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoguang Dou. A scholar is included among the top collaborators of Xiaoguang Dou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoguang Dou. Xiaoguang Dou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sheng, Qiuju, et al.. (2022). HBeAg-negative Patients with Chronic Hepatitis B Virus Infection and Normal Alanine Aminotransferase: Wait or Treat?. Journal of Clinical and Translational Hepatology. 10(5). 972–978. 6 indexed citations

Zhou, Yimeng, et al.. (2022). Hyperammonemia in a pregnant woman with citrullinemia type I: a case report and literature review. BMC Pregnancy and Childbirth. 22(1). 950–950. 2 indexed citations

Jiang, Hong, Chang–Xing Huang, Fuchun Zhang, et al.. (2022). Expert Consensus on the Prevention and Treatment of Hemorrhagic Fever with Renal Syndrome. SHILAP Revista de lepidopterología. 2(4). 224–232. 11 indexed citations

Sheng, Qiuju, Xiaoguang Dou, Chong Zhang, et al.. (2020). Programmed death 1, ligand 1 and 2 correlated genes and their association with mutation, immune infiltration and clinical outcomes of hepatocellular carcinoma. World Journal of Gastrointestinal Oncology. 12(11). 1255–1271. 14 indexed citations

Zhang, Chong, Zhengrong Yang, Ziyi Wang, et al.. (2020). HBV DNA and HBsAg: Early Prediction of Response to Peginterferon α-2a in HBeAg-Negative Chronic Hepatitis B. International Journal of Medical Sciences. 17(3). 383–389. 7 indexed citations

Zhang, Chong, Yu-Yu Wu, Xiaoguang Dou, et al.. (2020). Characteristics of Drug-Induced Liver Injury in Northeast China: Disease Spectrum and Drug Types. Digestive Diseases and Sciences. 65(11). 3360–3368. 4 indexed citations

Li, Yurong, Weijia Zhu, Qiuju Sheng, et al.. (2019). The Prevalence of HBV Infection: A Retrospective Study of 13 Years in a Public Hospital of Northeast China. Viral Immunology. 33(2). 99–104. 5 indexed citations

Chen, Xinyue, Xiaoguang Dou, Qing Xie, et al.. (2019). A Potential Functional Cure in Chinese HBeAg-negative Chronic Hepatitis B Patients Treated with Peg-interferon Alpha-2a. Journal of Clinical and Translational Hepatology. 7(X). 1–9. 6 indexed citations

Wu, Di, Meifang Han, Yong‐Ping Chen, et al.. (2019). Sequential combination therapy with interferon, interleukin-2 and therapeutic vaccine in entecavir-suppressed chronic hepatitis B patients: the Endeavor study. Hepatology International. 13(5). 573–586. 34 indexed citations

10.

Sheng, Qiuju, et al.. (2018). Hepatitis B virus serosurvey and awareness of mother-to-child transmission among pregnant women in Shenyang, China. Medicine. 97(22). e10931–e10931. 26 indexed citations

11.

Hou, Jinlin, Fuqiang Cui, Yang Ding, et al.. (2018). Management Algorithm for Interrupting Mother-to-Child Transmission of Hepatitis B Virus. Clinical Gastroenterology and Hepatology. 17(10). 1929–1936.e1. 47 indexed citations

12.

Sheng, Qiuju, Yang Ding, Baijun Li, et al.. (2018). Efficacy and safety of nucleos(t)ide analogues to prevent hepatitis B virus mother-to-child transmission in pregnant women with high viremia: real life practice from China. International Journal of Medical Sciences. 15(8). 796–801. 14 indexed citations

13.

Zhang, Wenhong, Dazhi Zhang, Xiaoguang Dou, et al.. (2018). Consensus on Pegylated Interferon Alpha in Treatment of Chronic Hepatitis B. Journal of Clinical and Translational Hepatology. 6(1). 1–10. 20 indexed citations

14.

Ma, Ying, et al.. (2016). Association between clinical features and YMDD mutations in patients with chronic hepatitis B following lamivudine therapy. Experimental and Therapeutic Medicine. 12(2). 847–853. 1 indexed citations

15.

Fu, Xiaoyu, Deming Tan, Xiaoguang Dou, Jinjun Chen, & Juan Wu. (2016). A multi-center clinical study comparing Sansure Magb and CAP/CTM HBV tests in the quantitative detection of HBV DNA. The Journal of Infection in Developing Countries. 10(7). 755–761. 4 indexed citations

16.

Shang, Jia, Xiaoyuan Xu, Xinyue Chen, et al.. (2015). Efficacy and related factors of pegylated interferon α-2a plus ribavirin therapy for chronic hepatitis C in non-responders. 8(3). 232–237. 1 indexed citations

17.

Zhang, Lijuan, et al.. (2014). Role of Th1/Th2 cytokines in serum on the pathogenesis of chronic hepatitis C and the outcome of interferon therapy. Genetics and Molecular Research. 13(4). 9747–9755. 20 indexed citations

18.

Kong, Juan, Yang Ding, Cong Zhang, et al.. (2013). Severe Vitamin D-Deficiency and Increased Bone Turnover in Patients with Hepatitis B from Northeastern China. Endocrine Research. 38(4). 215–222. 5 indexed citations

19.

Zhang, Lin, et al.. (2012). Mutations in different regions of the genome of hepatitis C virus genotype 1b and association with response to interferon therapy. International Journal of Molecular Medicine. 30(6). 1438–1442. 1 indexed citations

20.

Dou, Xiaoguang, et al.. (2002). Gene expression of NS5a strong antigenic regions of hepatitis C virus in E.coli and detection of their antigenicity.. PubMed. 1(3). 383–7. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact